CN101500549A - 酪蛋白复合物 - Google Patents

酪蛋白复合物 Download PDF

Info

Publication number
CN101500549A
CN101500549A CNA2007800294910A CN200780029491A CN101500549A CN 101500549 A CN101500549 A CN 101500549A CN A2007800294910 A CNA2007800294910 A CN A2007800294910A CN 200780029491 A CN200780029491 A CN 200780029491A CN 101500549 A CN101500549 A CN 101500549A
Authority
CN
China
Prior art keywords
resveratrol
casein
complex
solution
complex according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800294910A
Other languages
English (en)
Chinese (zh)
Inventor
齐-程·陈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of CN101500549A publication Critical patent/CN101500549A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA2007800294910A 2006-08-09 2007-08-02 酪蛋白复合物 Pending CN101500549A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06016660.0 2006-08-09
EP06016660 2006-08-09

Publications (1)

Publication Number Publication Date
CN101500549A true CN101500549A (zh) 2009-08-05

Family

ID=37460260

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800294910A Pending CN101500549A (zh) 2006-08-09 2007-08-02 酪蛋白复合物

Country Status (8)

Country Link
US (1) US8642736B2 (enExample)
EP (1) EP2049091B1 (enExample)
JP (1) JP5493189B2 (enExample)
CN (1) CN101500549A (enExample)
AT (1) ATE493122T1 (enExample)
DE (1) DE602007011627D1 (enExample)
ES (1) ES2358367T3 (enExample)
WO (1) WO2008017415A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102939017A (zh) * 2010-03-11 2013-02-20 斯托克里-丰康普公司 用于稳定水不溶性生物活性化合物水分散体的方法
CN103859423A (zh) * 2014-04-09 2014-06-18 青岛博之源生物技术有限公司 一种抗癌的花生蛋白粉及制备方法
CN105491988A (zh) * 2013-03-15 2016-04-13 格兰比亚营养物(爱尔兰)有限公司 用于提高治疗性化合物的生物利用度的产品和方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008088123A (ja) * 2006-10-03 2008-04-17 Oriza Yuka Kk 美肌用組成物
JP2008255020A (ja) * 2007-04-02 2008-10-23 Fujifilm Corp 抗老化皮膚外用剤
US20110129590A1 (en) * 2009-05-27 2011-06-02 Kathryn Deibler Beverage Product with Resveratrol
JP2011046660A (ja) * 2009-08-28 2011-03-10 Fujifilm Corp マトリックスメタロプロテアーゼ−２（ｍｍｐ−２）阻害剤
JP5820115B2 (ja) * 2010-01-14 2015-11-24 武義 浦田 経口摂取用組成物
US20120070475A1 (en) * 2010-03-11 2012-03-22 Pepsico, Inc Zero Calorie Polyphenol Aqueous Dispersions
JPWO2012043680A1 (ja) * 2010-09-29 2014-02-24 富士フイルム株式会社 水系皮膚外用剤
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US10983119B2 (en) * 2016-01-25 2021-04-20 General Electric Company Device for rapid diagnostic tests to detect antigens with improved sensitivity
CN112126519B (zh) * 2020-09-16 2022-04-29 江南大学 一种制备共包埋双重抗氧化剂的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2820975B1 (fr) * 2001-02-21 2004-03-12 Oreal Composition pour application topique comprenant au moins un hydroxystilbene et au moins un polyol pour solubiliser l'hydroxystilbene
ITMI20010528A1 (it) * 2001-03-13 2002-09-13 Istituto Biochimico Pavese Pha Complessi di resveratrolo con fosfolipidi loro preparazione e composizioni farmaceutiche e cosmetiche
ES2190771B2 (es) * 2002-01-24 2004-03-01 Univ Alicante Procedimiento para la produccion de resveratrol en cultivos celulares.
KR100757724B1 (ko) * 2002-10-21 2007-09-11 로레알 친유성 화합물의 용해 방법, 및 화장 조성물
US20070009455A1 (en) 2003-05-26 2007-01-11 Hyo-Jung Kim Whitening and antionxidative cosmetic composition containing resveratrol and method for preparing the same
WO2007122613A1 (en) * 2006-04-20 2007-11-01 Technion Research And Development Foundation Ltd. Casein micelles for nanoencapsulation of hydrophobic compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102939017A (zh) * 2010-03-11 2013-02-20 斯托克里-丰康普公司 用于稳定水不溶性生物活性化合物水分散体的方法
CN105491988A (zh) * 2013-03-15 2016-04-13 格兰比亚营养物(爱尔兰)有限公司 用于提高治疗性化合物的生物利用度的产品和方法
CN103859423A (zh) * 2014-04-09 2014-06-18 青岛博之源生物技术有限公司 一种抗癌的花生蛋白粉及制备方法

Also Published As

Publication number Publication date
WO2008017415A1 (en) 2008-02-14
EP2049091A1 (en) 2009-04-22
DE602007011627D1 (de) 2011-02-10
ATE493122T1 (de) 2011-01-15
JP2010500303A (ja) 2010-01-07
US8642736B2 (en) 2014-02-04
ES2358367T3 (es) 2011-05-10
US20100099607A1 (en) 2010-04-22
EP2049091B1 (en) 2010-12-29
JP5493189B2 (ja) 2014-05-14

Similar Documents

Publication Publication Date Title
CN101500549A (zh) 酪蛋白复合物
CA2146633C (en) Concentrated bioavailable calcium source
CA2852289A1 (en) Nutritional phytonutrient compositions
JP4469605B2 (ja) 濃縮物、その製造方法、並びに濃縮物の使用方法
KR102020586B1 (ko) 동식물 복합 추출물을 함유하는 고령친화 식품 및 그의 제조 방법
CA2339125A1 (en) Novel chitosan-containing liquid compositions and methods for their preparation and use
JPH04501511A (ja) 安定なグアー小麦粉を含有する液体飲料およびチューブ栄養
CN101652081B (zh) 含有高浓度钠的液态营养组合物及其生产方法
Valentina et al. Specialized hypocholesterolemic foods: Ingredients, technology, effects
JP2004504824A (ja) 繊維処方
JPH0272843A (ja) 糖アルコールを含有するミネラル補給剤
JP5281895B2 (ja) カルシウム吸収促進剤
JP7107422B2 (ja) エラスチンと鉄を含む飲料
Kundalia et al. Nutritional profile, functional characteristics, health benefits, and potential application of edible gum (Gond)
JP7423179B2 (ja) ポリフェノールを含む食品
JPWO2020032100A1 (ja) フィトケミカル吸収促進用組成物
KR101306931B1 (ko) 골다공증 예방 효과를 가지는 유기태화 칼슘 강화 유단백질
RU2776298C1 (ru) Биологически активная добавка к пище на основе аскорбиновой кислоты и экстракта стевии
RU2542520C2 (ru) Безалкогольный напиток (варианты)
WO2025114873A1 (en) Composition in gel for oral administration
CA2532118A1 (en) Compositions and methods of addition for calcium supplementation in transparent beverages using tricalcium phosphate
CN119744998A (zh) 一种含天然成分的饮料组合物及其制备方法和应用
JP2024026806A (ja) ポリフェノールを含む食品
JP2020103244A (ja) 飲食用組成物
ITRM990260A1 (it) Integratore alimentare composto di biofenoli e fruttooligosaccaridi da impiegare tal quale o come ingrediente di prodottti alimentari dietet

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090805